Navigation Links
Researchers discover way to make cells in the eye sensitive to light

Researchers have discovered a way to make light sensitive cells in the eye by switching on a single gene. According to research published online today in Nature, the team from Imperial College London and the University of Manchester, have discovered that activating the melanopsin gene in the nerve cells causes them to become light responsive, or photoreceptive.

Using mouse cells, the researchers found that melanopsin could be used to make neurones light responsive. They found that as well as being sensitive to blue light, melanopsin uses light at different wavelengths to regenerate itself. In some forms of hereditary blindness photoreceptors are lost entirely, but the retinal ganglion cells, the cells which signal to the brain, remain intact. The researchers believe that by activating the melanopsin, these cells may gain the ability to sense and respond to light. Professor Mark Hankins, from Imperial College London and Charing Cross Hospital, and one of the papers authors, comments: "It is quite remarkable that the activation of a single gene can create a functional photoreceptor. It is an important proof of principle that melanopsin can make non-light sensitive cells receptive to light, and although not a cure, could have applications in treating some forms of blindness." Dr Rob Lucas, from the University of Manchester, and one of the paper's authors, adds: "The discovery that melanopsin is capable of making cells photosensitive has given us a unique opportunity to study the characteristics of this interesting protein. The textbook view of the eye is that it contains only two light sensing systems, the rods and cones. However, over the last few years it has become increasingly accepted that we have a third system, which uses melanopsin, that has lain undetected during decades of vigorous scientific investigation." Professor Hankins and Dr Lucas were part of the team who previously discovered a new light detection system in the eye, totally independent of the rods and cones, which were thought to be the only systems providing sight. They measured light-induced pupillary constriction in genetically modified mice that lacked melanopsin. When the mice lacking melanopsin were exposed to low light, their pupillary response was the same as normal mice, but when they were exposed to bright light their pupil constriction was incomplete. The researchers believe that while not a cure for blindness, the findings could lead to therapies for treating some forms of blindness, such as retinitis pigmentosa. Retinitis pigmentosa is a form of hereditary blindness where the rods and cones are destroyed, but the rest of the eye and retina remains intact. By switching on the melanopsin it could be possible to restore the eyes ability to respond to light. Although making cells in the eye responsive to light is not a cure for blindness, the team are collaborating with engineers from Imperial to develop a functional retinal prosthesis which would allow the information from the light responsive cells to be used by the brain to process images.
'"/>

Source:Eurekalert


Related biology news :

1. Researchers find how protein allows insects to detect and respond to pheromones
2. Researchers Uncover Key Step In Manufacture of Memory Protein
3. Researchers reveal the infectious impact of salmon farms on wild salmon
4. Researchers identify target for cancer drugs
5. Researchers discover molecule that causes secondary stroke
6. Researchers find missing genes of ancient organism
7. Researchers trace evolution to relatively simple genetic changes
8. Researchers add new tool to tumor-treatment arsenal
9. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
10. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
11. Researchers develop rapid diagnostic tool for pathogen identification

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2019)... ... July 26, 2019 , ... Worldwide Business with ... Technologies CEO Phil Deschamps to discuss their potential new treatment option to manage ... a neurotech company in the medical device industry that's focused on neurological wellness. ...
(Date:7/23/2019)... ... July 23, 2019 , ... My Gene ... today announced that the company has expanded its database of genetic resources to ... (FH), and Parkinson’s disease. , The expanded content comes following 23andMe’s June 2019 ...
(Date:7/21/2019)... ... July 20, 2019 , ... ... Technologies ( http://www.fluidimaging.com ) announced today the release of the biggest software ... imaging and characterization platform will provide a significant increase in productivity for ...
Breaking Biology News(10 mins):
(Date:8/4/2019)... ... ... Cirtec Medical Corporation, a strategic outsourcing partner for complex medical devices, including active implantables ... sq. ft. manufacturing facility in the Coyol free zone, located in Alajuela, Costa ... to be fully operational by the end of the year, will be the company’s ...
(Date:7/19/2019)... (PRWEB) , ... July 18, 2019 , ... ... known as “Ravi Everest,” will be joining forces with California-based charity Coalition Duchenne ... from July 20-22nd. Coalition Duchenne raises awareness and funding for Duchenne muscular dystrophy ...
(Date:7/9/2019)... (PRWEB) , ... July 08, 2019 , ... Today, at ... Iowa, the National Corn Growers Association (NCGA) announced the winners of the ... improve a product or process using field corn to produce biobased materials. , “Corn ...
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, Inc ... application to the FDA for use of a person’s own adipose-derived stem cells to ... osteoarthritis in the knee. This IND is the first of several planned clinical ...
Breaking Biology Technology: